Welcome to
Breckenridge Pharmaceutical, Inc.

 

Breckenridge Pharmaceutical, Inc. is a Towa Company. 

 TOWA PHARMACEUTICAL CO.,LTD.

We are an own label distributor that performs pharmaceutical marketing, sales and distribution in the U.S.  The company was founded in 1983 and markets a broad range of generic prescription products in several therapeutic categories and dosage forms, including tablets, capsules, liquids, suspensions, ophthalmics, nasal sprays, powders, transdermal patches, and injectable products.

The Breckenridge label is recognized nationwide by wholesalers, distributors, chains, managed care accounts, and retail pharmacies.

Breckenridge, headquartered in Berlin, Connecticut, markets products under more than 40 Abbreviated New Drug Applications (ANDAs) approved by the Food and Drug Administration (FDA).                                    

 

 

Latest News

Breckenridge Announces Final Approval of its ANDA for Asenapine Sublingual Tablets, 2.5 and 10mg Strengths (generic for Saphris®)

Dec 11,2020

Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted final approval of its Abbreviated New Drug Application for Asenapine Sublingual Tablets in 2.5mg and 10mg strengths (generic for Saphris®).  Breckenridge plans to launch these strengths immediately.  Additionally, the U.S. Food and Drug Administration granted tentative approval for the 5mg strength. This product was developed in collaboration with MSN Laboratories Private Limited. According to industry sales data, Saphris® generated annual sales of $239 million during the twelve months ending September 2020.

About Breckenridge:

Breckenridge Pharmaceutical, Inc., a subsidiary of Towa Pharmaceutical (Osaka, Japan), partners with manufacturers nationwide and around the world to bring quality, cost-effective generic pharmaceuticals to U.S. patients.  With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and lives of the patients we and our customers serve.

www.bpirx.com

About MSN:

MSN Group is the fastest growing research based pharmaceutical company headquartered in India. Founded in 2003 with a mission to make health care affordable, MSN has nine API and five finished dosage facilities in Hyderabad and the U.S. The Group has an integrated R&D center for both API and formulation under one roof, dedicated to research and development of pharmaceuticals. With its core focus on speed and consistency in delivery, MSN has achieved more than 650 national and international patents, is world no. 1 in active U.S. DMF filings, has a product portfolio featuring over 380 APIs and over 250 formulations covering over 35 major therapies and has won the trust of more than 40,000,000 customers across 65 countries worldwide.

Read More >>

Breckenridge Announces Final Approval of its ANDA for Pomalidomide Capsules (generic for Pomalyst®)

Nov 13,2020

Breckenridge Pharmaceutical, Inc. announced today that the U.S. Food and Drug Administration has approved Breckenridge’s Abbreviated New Drug Application for Pomalidomide Capsules (generic for Pomalyst®).

Breckenridge has partnered with Natco Pharma Limited for the development and manufacture of this product. According to industry sales data, Pomalyst had annual sales of $957 million during the twelve months ending September 2020. In addition, Celgene, Breckenridge and Natco have settled the U.S. district court litigation with respect to this product.

About Breckenridge:

Breckenridge Pharmaceutical, Inc., a subsidiary of Towa Pharmaceutical (Osaka, Japan), partners with manufacturers nationwide and around the world to bring quality, cost-effective generic pharmaceuticals to U.S. patients.  With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and lives of the patients we and our customers serve.

www.bpirx.com

About Natco:

Natco Pharma Limited is global generic pharmaceutical research, development, manufacturing and marketing company. The company was established in 1981 in India. Natco supplies pharmaceutical products to over 50 countries across the globe, including the United States. Natco focuses on the development and manufacturing of oncology and other specialty pharmaceuticals.

Read More >>

Towa completes acquisition of Esteve's Generic Division

Jan 31,2020

Berlin, CT January 31, 2020 – Breckenridge Pharmaceutical, Inc. announced today that Towa Pharmaceutical Co., Ltd. has completed its acquisition of Esteve’s generics division, including Breckenridge.

 

Towa Pharmaceutical, based in Osaka, Japan, has been dedicated to the research and development, production, and marketing of generic drugs since 1951. With a team of more than 3,100 employees, its annual sales were 105,104 million yen for the year ended March 31, 2019. Towa’s shares are listed on the Tokyo Stock Exchange (TSE).

 

Read More >>

Product Search

All brand names are registered trademarks of their respective owner(s).